Attralus set for amyloidosis asset’s European orphan designations
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has given positive opinions for the awarding of an…
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has given positive opinions for the awarding of an…
AstraZeneca has highlighted both the economic and environmental benefits of implementing early, targeted screening for chronic kidney disease (CKD). CKD…
Johnson & Johnson (J&J) has announced positive topline results for nipocalimab in two rare disease indications - generalised myasthenia gravis…